Flywire Jumps on Earnings as Analysts Lift Targets

Flywire reported results on November 3 and walked into an immediate wave of analyst target increases, putting the stock at the centre of a classic post-earnings repricing debate: the numbers were good enough to move the Street, but options positioning had already priced in an unusually cautious setup, and short interest at nearly 10% of the float is a reminder that not everyone is convinced.

The clearest post-results signal came from the analyst community, which moved decisively upward. JP Morgan's Tien-Tsin Huang raised his target to $23 from $20 while holding a Neutral rating. Morgan Stanley's James Faucette, whose Overweight view has been consistent, lifted to $26 from $24. B. Riley and BTIG both raised to $25 and $22 respectively, each reiterating Buy. The direction of travel is uniform: targets are going up across the board, with the Street's mean now at $21.21, implying modest upside from the current $19.15 close. The bull case is rooted in Flywire's platform diversification, with Travel, Healthcare, and B2B reducing historical dependence on cross-border Education, now below 60% of revenue versus over 70% historically. Bears counter that the downside scenario cuts CY27 EBITDA to around $183M, roughly 15% below the base, and that Education is structurally under pressure, with UK sponsored study visa applications running 30% below year-to-date levels and Canada new study permits down approximately 40% through April.

Positioning had turned defensively cautious even before the earnings print landed. The put/call ratio reached 8.57 on November 3, the highest reading of the past 52 weeks and 2.3 standard deviations above its 20-day mean of 7.16. That is a significant skew toward protective puts, reflecting demand for downside cover going into the results. The borrow market, by contrast, tells a looser story: availability is running at 426%, meaning there are more than four shares available to borrow for every share currently short, well above the 52-week tightest level of 376%. Cost to borrow is 0.38%, near a one-month low after falling 32% over the past month. There is no squeeze pressure in the lending pool. Short interest has also been declining: at 9.7% of the free float, it has dropped roughly 1.2% over the past week and 3.5% over the past month, pulled from a peak around 10.6% in mid-October. Shorts are gradually covering rather than pressing the position.

The valuation picture looks measured rather than stretched. The stock trades at a P/E of 14.6 and EV/EBITDA of 9.4, both of which have compressed modestly over the past 30 days even as the price has gained 9% on the month. The EPS momentum factor scores rank in the 84th and 85th percentiles on 30- and 90-day windows, and the EPS surprise score is in the 81st percentile, suggesting a consistent pattern of beating estimates. The short score of 63.2 reflects moderate short-side pressure but has eased from 65.3 a week ago, consistent with the gradual short covering visible in the SI data.

The ownership register has seen active movement. Voss Capital, the largest holder at 11.3% of shares, has been adding and filed a 13G/A in April showing its stake at 12.1%. Wasatch Advisors reported a substantial increase of 2.8 million shares in the most recent period. On the other side, Temasek trimmed by roughly 1.96 million shares to 3.5% of the class, below the 5% threshold where further disclosure is not required. Cadian Capital has also edged below 5%. Insider activity is mechanically net negative on the 90-day window, with roughly $16.3 million sold and net shares of minus 865,000, but virtually all of it was executed under pre-arranged 10b5-1 plans, most notably repeated sales by David R. King and a sale of $390,000 by CFO Cosmin Pitigoi. Planned-schedule sales carry far less signal than discretionary ones.

One additional data point worth noting: retail attention, as measured by Wikipedia page views and ORTEX page traffic against the stock's own 90-day history, is running at a z-score of 5.5 as of mid-October, a marked spike in informal interest relative to the recent baseline.

The next scheduled earnings event is not until February 23, 2027, leaving 111 days for the post-results dust to settle. The key question between now and then is whether Travel and B2B momentum can offset any further deterioration in Education visa flows, and whether the analyst target upgrades drawn by this week's print are enough to shift the short thesis that has kept nearly 10% of the float borrowed for most of the autumn.